We are live on ! Find out more
FRTX

Fresh Tracks Therapeutics, Inc. Common Stock
FRTX

Delisted

FRTX was delisted on the 18th of December, 2023.

Back to rankings

19 hedge funds and large institutions have $3.67M invested in Fresh Tracks Therapeutics, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 1

167% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 3

90% more capital invested

Capital invested by funds: $1.94M → $3.67M (+$1.73M)

36% more funds holding

Funds holding: 14 → 19 (+5)

Holders
19
Holders Change
+5
Holders Change %
+35.71%
% of All Funds
0.39%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
3
Reduced
1
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CH
CVI Holdings
Delaware
+$1.52M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$275K
3
SCM
Stonepine Capital Management
Oregon
+$174K
4
Millennium Management
Millennium Management
New York
+$162K
5
Renaissance Technologies
Renaissance Technologies
New York
+$143K

Top Sellers

Rank Fund Capital Flow
1
Northern Trust
Northern Trust
Illinois
-$13K
2
NFG
Next Financial Group
Texas
-$10K
3
Victory Capital Management
Victory Capital Management
Texas
-$2K
4
Bank of America
Bank of America
North Carolina
-$53
Name Holding Trade Value Shares
Change 		Change in
Stake
CH
1
CVI Holdings
Delaware
$1.28M +$1.52M +28,456 New
PCM
2
Palisade Capital Management
New Jersey
$951K – – –
Renaissance Technologies
3
Renaissance Technologies
New York
$485K +$143K +2,691 +33%
Vanguard Group
4
Vanguard Group
Pennsylvania
$353K +$275K +5,155 +192%
SCM
5
Stonepine Capital Management
Oregon
$147K +$174K +3,261 New
Millennium Management
6
Millennium Management
New York
$137K +$162K +3,035 New
MFG
7
Magnus Financial Group
New York
$105K – – –
Goldman Sachs
8
Goldman Sachs
New York
$74K +$87.9K +1,651 New
BlackRock
9
BlackRock
New York
$44K – – –
Susquehanna International Group
10
Susquehanna International Group
Pennsylvania
$21K +$24.9K +468 New
BSAM
11
Blue Square Asset Management
New York
$19K +$22.3K +418 New
Geode Capital Management
12
Geode Capital Management
Massachusetts
$15K – – –
Jane Street
13
Jane Street
New York
$12K +$13.6K +256 New
SSWM
14
Smith Salley Wealth Management
North Carolina
$12K +$14.1K +265 New
SPIA
15
Steward Partners Investment Advisory
New York
$10K +$9.48K +178 +363%
Bank of America
16
Bank of America
North Carolina
$2K -$53 -1 -3%
Morgan Stanley
17
Morgan Stanley
New York
$2K – – –
Northern Trust
18
Northern Trust
Illinois
– -$13K -249 Closed
NFG
19
Next Financial Group
Texas
– -$10K -184 Closed
Victory Capital Management
20
Victory Capital Management
Texas
– -$2K -55 Closed

FRTX Hedge Fund Activity: Q2 2020 in Review

19 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) for Q2 2020, worth a combined $3.67M — up 90% from $1.94M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new FRTX positions and 3 closed out — a net gain of 5 holders — while 3 added to existing stakes and 1 trimmed.

The largest buyer was CVI Holdings, opening a new position worth an estimated $1.52M. The largest seller was Northern Trust, exiting entirely with an estimated $13K sold.

  • 19 institutional investors held Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) as of Q2 2020, up from 14 in Q1 2020.
  • Funds reported $3.67M of Fresh Tracks Therapeutics, Inc. Common Stock stock for Q2 2020, up 90% quarter-over-quarter.
  • 8 funds opened new Fresh Tracks Therapeutics, Inc. Common Stock positions in Q2 2020 and 3 closed out, a net change of +5 holders.
  • The largest Fresh Tracks Therapeutics, Inc. Common Stock buyer in Q2 2020 was CVI Holdings, an estimated $1.52M added.
  • The largest Fresh Tracks Therapeutics, Inc. Common Stock seller in Q2 2020 was Northern Trust, an estimated $13K sold.

Based on aggregated 13F filings for Q2 2020.